Evidence map›Paper›PMID 36566234›Full record

ArticleNature communications2022

Force-tuned avidity of spike variant-ACE2 interactions viewed on the single-molecule level.

Rong Zhu, Daniel Canena, Mateusz Sikora, Miriam Klausberger, Hannah Seferovic, Ahmad Reza Mehdipour, Lisa Hain, Elisabeth Laurent, Vanessa Monteil, Gerald Wirnsberger and 9 more

Erratum issuedOpen access · goldAbstract read
In one paragraph

Article in Nature communications, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.3field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 45 citations in OpenAlex.

  1. Review
  2. Switching Spike Plasticity Shapes ACE2 Engagement Across SARS-CoV-2 Variants.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  3. Glycans Modulate the Adsorption of RBD Glycoproteins on Polarizable Surfaces.Journal of chemical information and modeling · 2026
    Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. The accomplices: Heparan sulfates and N-glycans foster SARS-CoV-2 spike:ACE2 receptor binding and virus priming.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Biophysical investigation of interactions between SARS-CoV-2 spike protein and neuropilin-1.Protein science : a publication of the Protein Society · 2023
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 6 countries.

Rong Zhu *Department of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria.
Daniel Canena *Department of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria.
Mateusz Sikora *Department of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.
Miriam KlausbergerDepartment of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences, Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-8409-454X
Hannah SeferovicDepartment of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria.
Ahmad Reza MehdipourDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany.
Lisa HainDepartment of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria.
Elisabeth LaurentDepartment of Biotechnology, Institute of Molecular Biotechnology, University of Natural Resources and Life Sciences, Vienna, Vienna, Austria.
Vanessa MonteilDepartment of Laboratory Medicine, Unit of Clinical Microbiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0002-2652-5695
Gerald WirnsbergerApeiron Biologics, Vienna, Austria.
Ralph WienekeInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0002-0767-4679
Robert TampéInstitute of Biochemistry, Biocenter, Goethe University Frankfurt, Frankfurt, Germany.ORCID http://orcid.org/0000-0002-0403-2160
Nikolaus F KienzlDepartment of Applied Genetics and Cell Biology, Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-8057-3930
Lukas MachDepartment of Applied Genetics and Cell Biology, Institute of Plant Biotechnology and Cell Biology, University of Natural Resources and Life Sciences, Vienna, Vienna, Austria.ORCID http://orcid.org/0000-0001-9013-5408
Ali MirazimiDepartment of Laboratory Medicine, Unit of Clinical Microbiology, Karolinska Institute and Karolinska University Hospital, Stockholm, Sweden.ORCID http://orcid.org/0000-0003-2371-6055
Yoo Jin OhDepartment of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria.ORCID http://orcid.org/0000-0002-9636-3329
Josef M PenningerInstitute of Molecular Biotechnology of the Austrian Academy of Sciences (IMBA), Vienna, Austria. josef.penninger@ubc.ca.ORCID http://orcid.org/0000-0002-8194-3777
Gerhard HummerDepartment of Theoretical Biophysics, Max Planck Institute of Biophysics, Frankfurt am Main, Germany. gerhard.hummer@biophys.mpg.de.ORCID http://orcid.org/0000-0001-7768-746X
Peter HinterdorferDepartment of Experimental Applied Biophysics, Johannes Kepler University Linz, Linz, Austria. peter.hinterdorfer@jku.at.ORCID http://orcid.org/0000-0003-2583-1305
Johannes Kepler University of Linz · ATGoethe University Frankfurt · DEInstitute of Molecular Biotechnology · ATBOKU University · ATApeiron Biologics (Austria) · ATKarolinska University Hospital · SESwedish Veterinary Agency · SEUniversity College Ghent · BEUniversity of Vienna · AT

Funding

Austrian Science Fund FWF I 3173Austrian Science Fund FWF J 4332Austrian Science Fund FWF P 31599Austrian Science Fund FWF V 584Austrian Science Fund FWF W 1224Austrian Science Fund FWF Z 271
6 · The paper itself

Abstract

Recent waves of COVID-19 correlate with the emergence of the Delta and the Omicron variant. We report that the Spike trimer acts as a highly dynamic molecular caliper, thereby forming up to three tight bonds through its RBDs with ACE2 expressed on the cell surface. The Spike of both Delta and Omicron (B.1.1.529) Variant enhance and markedly prolong viral attachment to the host cell receptor ACE2, as opposed to the early Wuhan-1 isolate. Delta Spike shows rapid binding of all three Spike RBDs to three different ACE2 molecules with considerably increased bond lifetime when compared to the reference strain, thereby significantly amplifying avidity. Intriguingly, Omicron (B.1.1.529) Spike displays less multivalent bindings to ACE2 molecules, yet with a ten time longer bond lifetime than Delta. Delta and Omicron (B.1.1.529) Spike variants enhance and prolong viral attachment to the host, which likely not only increases the rate of viral uptake, but also enhances the resistance of the variants against host-cell detachment by shear forces such as airflow, mucus or blood flow. We uncover distinct binding mechanisms and strategies at single-molecule resolution, employed by circulating SARS-CoV-2 variants to enhance infectivity and viral transmission.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19SARS-CoV-2Single Molecule ImagingSpike Glycoprotein, CoronavirusHumansVirus AttachmentAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID36566234
PMCPMC9789309
OpenAlexW4313315566

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.